Healthcare provider profile · identity verified

Thomas H Ball, MD

Internal Medicine · FORT MYERS, FL · NPI 1679596795

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	643	195
Amlodipine Besylate	Amlodipine Besylate	412	128
Losartan Potassium	Losartan Potassium	356	106
Levothyroxine Sodium	Levothyroxine Sodium	319	88
Lisinopril	Lisinopril	292	86
Metformin Hcl	Metformin Hcl	255	84
Rosuvastatin Calcium	Rosuvastatin Calcium	208	66
Omeprazole	Omeprazole	173	58
Allopurinol	Allopurinol	163	43
Pantoprazole Sodium	Pantoprazole Sodium	145	45
Metoprolol Succinate	Metoprolol Succinate	127	43
Tamsulosin Hcl	Tamsulosin Hcl	118	42
Simvastatin	Simvastatin	109	37
Metoprolol Tartrate	Metoprolol Tartrate	108	33
Eliquis	Apixaban	104	28
Ozempic	Semaglutide	100	22
Hydrochlorothiazide	Hydrochlorothiazide	94	27
Trazodone Hcl	Trazodone Hcl	87	32
Sertraline Hcl	Sertraline Hcl	78	26
Valsartan	Valsartan	78	23
Gabapentin	Gabapentin	77	25
Jardiance	Empagliflozin	75	26
Ezetimibe	Ezetimibe	65	23
Montelukast Sodium	Montelukast Sodium	61	19
Carvedilol	Carvedilol	59	24
Famotidine	Famotidine	58	20
Clopidogrel	Clopidogrel Bisulfate	53	13
Furosemide	Furosemide	50	18
Spironolactone	Spironolactone	50	17
Potassium Chloride	Potassium Chloride	47	17
Alendronate Sodium	Alendronate Sodium	46	14
Pioglitazone Hcl	Pioglitazone Hcl	46	12
Chlorthalidone	Chlorthalidone	44	15
Albuterol Sulfate Hfa	Albuterol Sulfate	43	21
Pravastatin Sodium	Pravastatin Sodium	43	15
Zolpidem Tartrate	Zolpidem Tartrate	42	suppressed
Alprazolam	Alprazolam	41	suppressed
Atenolol	Atenolol	39	11
Torsemide	Torsemide	39	13
Xarelto	Rivaroxaban	37	12
Cephalexin	Cephalexin	36	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	12
Escitalopram Oxalate	Escitalopram Oxalate	35	12
Fluticasone Propionate	Fluticasone Propionate	34	16
Finasteride	Finasteride	32	13
Duloxetine Hcl	Duloxetine Hcl	30	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Clonazepam	Clonazepam	29	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Glimepiride	Glimepiride	26	suppressed
Prednisone	Prednisone	26	19
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Irbesartan	Irbesartan	23	suppressed
Lovastatin	Lovastatin	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Pregabalin	Pregabalin	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Diazepam	Diazepam	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Lorazepam	Lorazepam	15	suppressed
Baclofen	Baclofen	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	13	suppressed
Xifaxan	Rifaximin	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Gemtesa	Vibegron	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Tramadol Hcl	Tramadol Hcl	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Ramipril	Ramipril	11	suppressed
Telmisartan	Telmisartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error